Clinical approach to skin eruptions induced by anti-TNF agents among patients with inflammatory bowel diseases: insights from a multidisciplinary IBD-DERMA clinic

Autor: Henit Yanai, Hadar Amir Barak, Jacob E Ollech, Irit Avni Biron, Idan Goren, Yifat Snir, Hagar Banai Eran, Yelena Broitman, Maya Aharoni Golan, Elena Didkovsky, Iris Amitay-Laish, Ayelet Ollech, Emmilia Hodak, Iris Dotan, Lev Pavlovsky

Publikováno v: Therapeutic Advances in Gastroenterology, Vol 14 (2021)

Background and Aims: Skin eruptions are prevalent among patients with inflammatory bowel diseases (IBD), often associated with therapies and frequently leading to dermatological consults and treatment interruptions. We aimed to assess the impact of j

Externí odkaz: https://doaj.org/article/88b32f4454734962ae309656aa9a48f8

Endoscopic Postoperative Recurrence in Crohn's Disease After Curative Ileocecal Resection with Early Prophylaxis by Anti-TNF, Vedolizumab or Ustekinumab: A Real-World Multicentre European Study

Autor: Henit Yanai, Anna Kagramanova, Oleg Knyazev, João Sabino, Shana Haenen, Gerassimos J Mantzaris, Katerina Mountaki, Alessandro Armuzzi, Daniela Pugliese, Federica Furfaro, Gionata Fiorino, David Drobne, Tina Kurent, Sharif Yassin, Nitsan Maharshak, Fabiana Castiglione, Roberto de Sire, Olga Maria Nardone, Klaudia Farkas, Tamas Molnar, Zeljko Krznaric, Marko Brinar, Elena Chashkova, Moran Livne Margolin, Uri Kopylov, Cristina Bezzio, Ariella Bar-Gil Shitrit, Milan Lukas, María Chaparro, Marie Truyens, Stéphane Nancey, Triana Lobaton, Javier P Gisbert, Simone Saibeni, Péter Bacsúr, Peter Bossuyt, Julien Schulberg, Frank Hoentjen, Chiara Viganò, Andrea Palermo, Joana Torres, Joana Revés, Konstantinos Karmiris, Magdalini Velegraki, Edoardo Savarino, Panagiotis Markopoulos, Eftychia Tsironi, Pierre Ellul, Cristina Calviño Suárez, Roni Weisshof, Dana Ben-Hur, Timna Naftali, Carl Eriksson, Ioannis E Koutroubakis, Kalliopi Foteinogiannopoulou, Jimmy K Limdi, Eleanor Liu, Gerard Surís, Emma Calabrese, Francesca Zorzi, Rafał Filip, Davide Giuseppe Ribaldone, Yifat Snir, Idan Goren, Hagar Banai-Eran, Yelena Broytman, Hadar Amir Barak, Irit Avni-Biron, Jacob E Ollech, Iris Dotan, Maya Aharoni Golan

Publikováno v: Journal of Crohn's and Colitis, 16, 12, pp. 1882-1892
JOURNAL OF CROHNS & COLITIS
Journal of Crohn's and Colitis, 16, 1882-1892

Background Endoscopic-post-operative-recurrence [ePOR] in Crohn’s disease [CD] after ileocecal resection [ICR] is a major concern. We aimed to evaluate the effectiveness of early prophylaxis with biologics and to compare anti-tumour necrosis factor

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed228cfd6a620d61ff07d1f9be9ff326
https://repository.ubn.ru.nl/handle/2066/288021

effectiveness of third-class biologic treatment in crohn’s disease: a multi-center retrospective cohort study

Autor: C. M. Alves, Henit Yanai, Morine Fibelman, Claire Liefferinckx, Marina Coletta, Hadar Amir-Barak, Johan Burisch, Afroditi Mpitouli, Manuel Barreiro-de Acosta, Mohamed Attauabi, Triana Lobaton, Mariann Rutka, Joshua Taylor, Konstantinos Karmiris, Javier P. Gisbert, Carla Marinelli, Kalliopi Foteinogiannopoulou, Daniela Pugliese, Edoardo Savarino, Borja Otero-Alvarin, V Domislović, Ariella Bar-Gil Shitrit, Alessandro Armuzzi, Zeljko Krznaric, Carl Eriksson, Mohamed Korani, Waqqas Afif, Jimmy K. Limdi, Nitsan Maharshak, Davide Giuseppe Ribaldone, A Cremer, G Suris, Tamás Molnár, Stéphane Nancey, Ioannis E. Koutroubakis, Jakob Benedict Seidelin, Caroline di Jiang, Uri Kopylov, Tim Raine, Pauliina Molander, Katja Tepes, Ahmad Albshesh, David Drobne, María Chaparro, Marie Truyens, Fernando Magro

Publikováno v: Albshesh, A, Taylor, J, Savarino, E V, Truyens, M, Armuzzi, A, Ribaldone, D G, Shitrit, A B G, Fibelman, M, Molander, P, Liefferinckx, C, Nancey, S, Korani, M, Rutka, M, Acosta, M B D, Domislovic, V, Suris, G, Eriksson, C, Alves, C, Mpitouli, A, Di Jiang, C, Tepeš, K, Coletta, M, Foteinogiannopoulou, K, Gisbert, J P, Amir-Barak, H, Attauabi, M, Seidelin, J, Afif, W, Marinelli, C, Lobaton, T, Pugliese, D, Maharshak, N, Cremer, A, Limdi, J K, Molnár, T, Otero-Alvarin, B, Krznaric, Z, Magro, F, Karmiris, K, Raine, T, Drobne, D, Koutroubakis, I, Chaparro, M, Yanai, H, Burisch, J & Kopylov, U 2021, ' Effectiveness of third-class biologic treatment in crohn’s disease : A multi-center retrospective cohort study ', Journal of Clinical Medicine, vol. 10, no. 13, 2914 . https://doi.org/10.3390/jcm10132914
JOURNAL OF CLINICAL MEDICINE
Dipòsit Digital de la UB
Universidad de Barcelona
Journal of Clinical Medicine, Vol 10, Iss 2914, p 2914 (2021)
Journal of Clinical Medicine
Volume 10
Issue 13

Background: Multiple studies have described the effectiveness of ustekinumab (UST) and vedolizumab (VDZ) in patients with Crohn’s disease (CD) failing anti- Tumor necrosis factors (TNFs)
however, the effectiveness of VDZ or UST as a third-clas

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f0e8db9f808dbe7ce7e105fbfbd61d0
https://doi.org/10.3390/jcm10132914

Sa1335 NEOPLASIA RISK AND RESECTION COMPLICATIONS IN GASTRIC HYPERPLASTIC POLYPS: WHAT IS WORSE?

Autor: Hadar Amir Barak, Roy Dekel, Fadi Kinaani, Nir Bar

Publikováno v: Gastroenterology. 158:S-321

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2e86ac383cb055258369300435ae8f82
https://doi.org/10.1016/s0016-5085(20)31502-x